IL94982A - History of herpes tetrapeptide with a side chain of converted aspartic acid in their preparation and pharmaceutical preparations containing - Google Patents

History of herpes tetrapeptide with a side chain of converted aspartic acid in their preparation and pharmaceutical preparations containing

Info

Publication number
IL94982A
IL94982A IL9498290A IL9498290A IL94982A IL 94982 A IL94982 A IL 94982A IL 9498290 A IL9498290 A IL 9498290A IL 9498290 A IL9498290 A IL 9498290A IL 94982 A IL94982 A IL 94982A
Authority
IL
Israel
Prior art keywords
asp
alkyl
phenyl
hydrogen
peptide
Prior art date
Application number
IL9498290A
Other languages
English (en)
Hebrew (he)
Other versions
IL94982A0 (en
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA000605061A external-priority patent/CA1340681C/en
Priority claimed from CA 2019006 external-priority patent/CA2019006C/en
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Publication of IL94982A0 publication Critical patent/IL94982A0/xx
Publication of IL94982A publication Critical patent/IL94982A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
IL9498290A 1989-07-07 1990-07-05 History of herpes tetrapeptide with a side chain of converted aspartic acid in their preparation and pharmaceutical preparations containing IL94982A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA000605061A CA1340681C (en) 1989-07-07 1989-07-07 Antiherpes tetrapeptides having a substituted aspartic acid side chain
CA 2019006 CA2019006C (en) 1990-06-14 1990-06-14 Antiherpes tetrapeptide derivatives having a cycloalkyl substituted aspartic acid side chain

Publications (2)

Publication Number Publication Date
IL94982A0 IL94982A0 (en) 1991-06-10
IL94982A true IL94982A (en) 1995-11-27

Family

ID=25672868

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9498290A IL94982A (en) 1989-07-07 1990-07-05 History of herpes tetrapeptide with a side chain of converted aspartic acid in their preparation and pharmaceutical preparations containing

Country Status (6)

Country Link
EP (1) EP0411333B1 (de)
JP (1) JP2879799B2 (de)
AT (1) ATE123294T1 (de)
AU (1) AU643403B2 (de)
DE (1) DE69019786T2 (de)
IL (1) IL94982A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340682C (en) * 1989-07-07 1999-07-27 Pierre Lavallee Antiviral peptides having a 2-oxoalkyl amino acid side chain
AU643636B2 (en) * 1989-07-07 1993-11-18 Bio-Mega/Boehringer Ingelheim Research Inc. Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain
EP0560267B1 (de) 1992-03-12 1998-08-19 Boehringer Ingelheim (Canada) Ltd. Isosterische Peptidderivate gegen Herpes
US5846941A (en) * 1992-03-12 1998-12-08 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives II

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795740A (en) * 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
EP0292255A3 (de) * 1987-05-22 1990-08-22 Merck & Co. Inc. Hemmungsstoff für Ribonukleotid-Reduktase
CA1327869C (en) * 1989-02-17 1994-03-15 Yvan Guindon Ribonucleotide reductase inhibitors
CA1340682C (en) * 1989-07-07 1999-07-27 Pierre Lavallee Antiviral peptides having a 2-oxoalkyl amino acid side chain
AU643636B2 (en) * 1989-07-07 1993-11-18 Bio-Mega/Boehringer Ingelheim Research Inc. Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain

Also Published As

Publication number Publication date
JPH03215495A (ja) 1991-09-20
EP0411333A1 (de) 1991-02-06
JP2879799B2 (ja) 1999-04-05
IL94982A0 (en) 1991-06-10
EP0411333B1 (de) 1995-05-31
AU643403B2 (en) 1993-11-11
DE69019786T2 (de) 1995-11-16
ATE123294T1 (de) 1995-06-15
AU5877690A (en) 1991-01-10
DE69019786D1 (de) 1995-07-06

Similar Documents

Publication Publication Date Title
US5484771A (en) Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus
US6313095B1 (en) Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain
EP0493770B1 (de) Antiherpes-Zusammensetzungen
EP0411334B1 (de) Pentapeptidderivate, wirksam gegen Herpes, die eine ersetzte Asparaginsäureseitenkette enthalten
EP0411332B1 (de) Antivirale Peptide, die eine 2-Ketoalkylaminosäureseitenkette enthalten
EP0411333B1 (de) Antiherpes-Tetrapeptid-Derivate mit einer substituierten Seitenkette aus Asparaginsäure
CA1340683C (en) Antiherpes pentapeptides having a substituted aspartic acid side chain
EP0408973B1 (de) Antiherpes-Pentapeptide
US5149778A (en) Cyclic peptides for treating herpes infections
US5258493A (en) Cyclic peptides for treating herpes infections
CA2019005C (en) Antiherpes pentapeptide derivatives having a cycloalkyl substituted aspartic acid side chain
CA2019006C (en) Antiherpes tetrapeptide derivatives having a cycloalkyl substituted aspartic acid side chain
US5648337A (en) Antiherpes pentapeptides
EP0560274B1 (de) Peptidderivate mit einem Ureido-N-Terminus gegen Herpes
US5830864A (en) Antiherpes peptide derivatives having a ureido n-terminus
NZ234373A (en) Acylated n-terminal tetrapeptides having an esterified or amidified aspartic acid residue and optionally substituted at the c-terminal by 5-1h-tetrazolyl; use in treatment of herpes virus infections

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void